3Moss E L,Hollingworth J,Reynolds T M.The role of CA125in clinical practice[J].Clin Pathol,2005,58(3):308-312.
二级参考文献21
1Moss EL, Hollingworth J, Reynolds TM. The role of CA125 in clinical practice.J Clin Pathol,2005,58:308-312.
2Jacobs I. Discussion:ovarian cancer screening. Gynecol Oncol,2003,88:80-83.
3Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 2002, 359(9306): 572-577.
4Kozak KR, Amneus MW, Pusey SM,et al. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis.Proc Natl Acad Sci U S A, 2003,100:12343-12348.
5Kalofonos HP, Giannakenas C, Kosmas C, et al. Radioimmunoscintigraphy in patients with ovarian cancer. Acta Oncol,1999,38:629-634.
6Lieberman G, Buscombe JR, Hilson AJ, et al. Preoperative diagnosis of ovarian carcinoma with a novel monoclonal antibody.Am J Obstet Gynecol,2000,183:534-540.
7Wilder JL, Pavlik E, Straughn JM,et al. Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation. Gynecol Oncol,2003,89:233-235.
8Topuz E, Aydiner A, Saip P, et al. Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer.Eur J Gynaecol Oncol,2000,21:599-602.
9Yeh LS, Hung YC, Kao A, et al. Tissue polypeptide specific antigen (TPS) and carbohydrate antigen 125 (CA-125) in the early prediction of recurrent ovarian cancer.Anticancer Res,2002,22:3669-3671.
10Pannu HK, Horton KM, Fishman EK. Thin section dual-phase multidetector-row computed tomography detection of peritoneal metastases in gynecologic cancers.J Comput Assist Tomogr,2003,27:333-340.
5Bouanene H, Miled A. Tumor Marker CA125: biochemical and molecular properties[J]. Bull Cancer, 2009, 96(5) : 597-601.
6Piura B, Rabinovich A, Leron E, et al. Peritoneal tuberculosis mimicking ovarian carcinoma with ascites and elevated serum CA 125:case report and review of literature[J]. Eur J Gynaeeol Oncol, 2002, 23(2):120-122.
7Koc S, Beydilli G, Tulunay G, et al. Peritoneal tuberculosis mimicking advanced ovarian cancer: a retrospective review of 22 cases[J]. Gynecol Oncol, 2006, 103(2) :565-569.
8Lian L J, W J. The clinical application of monoclonal antibody of ovarian carcinoma[J]. Chinese Journal of Obstetrics and Gynecology, 1985,20 (5) : 257-264.
9Bast RC Jr, Klug TL, St John E, et al. A radioimmunoas- say using a monoclonal antibody to monitor the course of epithelial ovarian cancer[J]. N Engl J Med, 1983, 309 (15) :883-887.
10Atacag T. Diagnostic value of thrombocytosis and high CA 125 level in women with adnexal rnasses[J]. Eur J Gynaecol Oncol, 2012,33 (5) . 517-520.
